Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
1.210
+0.130 (12.04%)
At close: Mar 23, 2026, 4:00 PM EDT
1.220
+0.010 (0.83%)
After-hours: Mar 23, 2026, 7:38 PM EDT
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $7.68 million as of March 23, 2026. Its market cap has increased by 8.59% in one year.
Market Cap
7.68M
Enterprise Value
8.01M
1-Year Change
8.59%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $7.68M, a decrease of -98.15%. That is a compound annual growth rate of -42.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 8.80M | 1.89% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SciSparc | 7.51M |
| Xenetic Biosciences | 7.47M |
| Evogene | 7.38M |
| PharmaCyte Biotech | 7.37M |
| Alaunos Therapeutics | 7.19M |
| Alzamend Neuro | 6.96M |
| Addex Therapeutics | 6.91M |
| GridAI Technologies | 6.89M |